fbpx

Department of Neurodegenerative Science

43 results.

March 6, 2024 Van Andel Institute announces 2024 Public Lecture Series

GRAND RAPIDS, Mich. (March 6, 2024) — Van Andel Institute’s free Public Lecture Series returns March 20. This year’s lineup tackles topics such as cancer and nutrition,…

February 23, 2024 Cure Parkinson's and Van Andel Institute fund Phase 2 clinical trial of dapansutrile for Parkinson’s

LONDON (Feb. 23, 2024) — Cure Parkinson’s and Van Andel Institute are delighted to announce funding for a Phase 2 clinical trial…

February 15, 2024 How a ‘blockbuster’ treatment for diabetes and obesity might slow or stop Parkinson’s

A “blockbuster” weight loss medication hailed as the “2023 Breakthrough of the Year” by Science also may have game-changing implications for Parkinson’s…

January 11, 2024 ‘A Grand Plan' for achieving breakthroughs and improving health

Collaboration, innovation and robust science are a powerful combination, one that drives discoveries aimed at improving health for generations to come. The era of siloed…

November 14, 2023 Inflammation and loss of protective mechanisms in the brain linked to suicide risk

GRAND RAPIDS, Mich. (Nov. 14, 2023) — A first-of-its-kind study has identified overactive inflammation and loss of critical protection mechanisms in the brain as potential…

October 18, 2023 New model provides window into Alzheimer’s disease development

GRAND RAPIDS, Mich. (Oct. 18, 2023) — A new model developed by Van Andel Institute, Lund University and

September 29, 2023 2023 Tom Isaacs Award honors Dr. Natasha Fothergill-Misbah

GRAND RAPIDS (Mich.) Sept. 29, 2023 — Cure Parkinson’s and Van Andel Institute (VAI) are delighted to announce Dr. Natasha Fothergill-Misbah, Research…

August 28, 2023 Preliminary phase 2 trial results of lixisenatide presented

Copenhagen, Denmark (August 28, 2023) — A one-year, phase 2 clinical trial of Type 2 diabetes drug lixisenatide has reported positive early results, which indicate…